1
TÍTULO: Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study
AUTORES: Alain Vergnenegre; Egbert F Smit; Elisabeth Toy; Barbara Parente; Stephan Schmitz; Kees Kraaij; Victoria Soldatenkova; Carla Visseren Grul; Giovanni Zanotti; Kaisa Taipale; Denis Moro Sibilot;
PUBLICAÇÃO: 2012, FONTE: CURRENT MEDICAL RESEARCH AND OPINION, VOLUME: 28, NÚMERO: 8
INDEXADO EM: Scopus WOS CrossRef
2
TÍTULO: High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non-Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
AUTORES: Guenaelle Levallet; Emmanuel Bergot; Martine Antoine; Christian Creveuil; Adriana O Santos ; Michelle Beau Faller; Florence de Fraipont; Elisabeth Brambilla; Jerome Levallet; Franck Morin; Virginie Westeel; Marie Wislez; Elisabeth Quoix; Didier Debieuvre; Fatemeh Dubois; Isabelle Rouquette; Jean Louis Pujol; Denis Moro Sibilot; Jacques Camonis; Gerard Zalcman;
PUBLICAÇÃO: 2012, FONTE: MOLECULAR CANCER THERAPEUTICS, VOLUME: 11, NÚMERO: 5
INDEXADO EM: Scopus WOS CrossRef: 71
3
TÍTULO: Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study
AUTORES: Denis Moro Sibilot; Alain Vergnenegre; Egbert F Smit; Elisabeth Toy; Barbara Parente; Stephan Schmitz; Kees Kraaij; Carla Visseren Grul; Victoria Soldatenkova; Jorge Arellano; Claudia Leteneux;
PUBLICAÇÃO: 2010, FONTE: CURRENT MEDICAL RESEARCH AND OPINION, VOLUME: 26, NÚMERO: 11
INDEXADO EM: Scopus WOS